In our February issue of Pharmaceutical Executive
FEATURES
Cover Story
Region in Reform? Pharma’s Challenging Value Message in Latin America
William Looney
A panel of biopharma executives responsible for the Latin America business discuss investment, market access, and reimbursement issues in this key regional growth market for the life sciences industry. |
Interview
Market Access: Current and Future States
Julian Upton
With the push toward value-based healthcare set to accelerate even more in 2017, Takeda’s VP of global market access, Mel Formica, discusses the evolution of this all-important engine for medical innovation and bottom-line returns. |
Interview
Market Access: A UK Perspective
Julian Upton
Pharm Exec speaks with Ramita Tandon, executive vice president, ICON Commercialization & Outcomes, about the potential impact of UK and European regulators’ market access plans for the industry. |
From the Editor
When You Need Experts, Use Them
Lisa Henderson
Here's to hoping that PhRMA's new public education campaign advances the voice of the patient in its messaging, writes Pharm Exec’s new Editor-in-Chief, Lisa Henderson. |
Collaborations
The Trouble with Pharma Partnerships… And How to Fix Them
Keith Bailey
Keith Bailey offers a new approach to reviving industry collaborations. |
 |
ALSO IN THIS ISSUE
Pricing Pressures and Policy Changes
Jill Wechsler
Congress is poised to tackle exorbitant drug prices through health reform and FDA legislation …Read more
Obstacles to Europe’s HTA Ambitions
Reflector
The pursuit of a harmonized European approach to assessing the value of new medicines continues to face roadblocks …Read more
CMED: The “Curupira” of Brazil’s Pharma Market
Rafael Alencar, Mariana Torgal, Catarina Costa Pinheiro
Outlining one country’s unique price-setting model for novel drugs—and the resulting pre-launch strategies for manufacturers …Read more
|
|
| |
| WEBCASTS |
| Commercializing Drugs with Companion Diagnostics |
| How the Life Sciences Cloud Coalition Is Driving Greater Innovation and Collaboration for Sponsors |
Supporting internal and external decision-making through effective MSL activities
|
Achieving Success in the Biosimilar Market
|
Why Patient Support Programs Need a Personal Approach
|
